150 related articles for article (PubMed ID: 35406538)
1. Prognostic Impact of Circulating Methylated Homeobox A9 DNA in Patients Undergoing Treatment for Recurrent Ovarian Cancer.
Faaborg L; Andersen RF; Waldstrøm M; Henriksen JR; Adimi P; Jakobsen A; Steffensen KD
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406538
[TBL] [Abstract][Full Text] [Related]
2. Circulating HOXA9-methylated tumour DNA: A novel biomarker of response to poly (ADP-ribose) polymerase inhibition in BRCA-mutated epithelial ovarian cancer.
Rusan M; Andersen RF; Jakobsen A; Steffensen KD
Eur J Cancer; 2020 Jan; 125():121-129. PubMed ID: 31865042
[TBL] [Abstract][Full Text] [Related]
3. The prognostic impact of circulating homeobox A9 methylated DNA in advanced non-small cell lung cancer.
Wen SWC; Andersen RF; Hansen TF; Nyhus CH; Hager H; Hilberg O; Jakobsen A
Transl Lung Cancer Res; 2021 Feb; 10(2):855-865. PubMed ID: 33718027
[TBL] [Abstract][Full Text] [Related]
4. The Clinical Impact of Methylated Homeobox A9 ctDNA in Patients with Non-Resectable Biliary Tract Cancer Treated with Erlotinib and Bevacizumab.
Andersen LB; Mahler MSK; Andersen RF; Jensen LH; Raunkilde L
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230519
[TBL] [Abstract][Full Text] [Related]
5. HOXA9-methylated DNA as a diagnostic biomarker of ovarian malignancy.
Faaborg L; Jakobsen A; Waldstrøm M; Petersen CB; Andersen RF; Steffensen KD
Biomark Med; 2021 Oct; 15(15):1309-1317. PubMed ID: 34514844
[No Abstract] [Full Text] [Related]
6. Comparison of Mutated KRAS and Methylated HOXA9 Tumor-Specific DNA in Advanced Lung Adenocarcinoma.
Wen SWC; Andersen RF; Petersen LMS; Hager H; Hilberg O; Jakobsen A; Hansen TF
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322500
[TBL] [Abstract][Full Text] [Related]
7. HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients.
Lissa D; Ishigame T; Noro R; Tucker MJ; Bliskovsky V; Shema S; Beck JA; Bowman ED; Harris CC; Robles AI
Lung Cancer; 2018 Aug; 122():151-159. PubMed ID: 30032824
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of homeobox A9 (HOXA9) methylation in solid tumors: a systematic review and meta-analysis.
Cai H; Ke ZB; Dong RN; Chen H; Lin F; Zheng WC; Chen SH; Zhu JM; Chen SM; Zheng QS; Wei Y; Xue XY; Xu N
Transl Cancer Res; 2021 Oct; 10(10):4347-4354. PubMed ID: 35116293
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of microRNA-196b Accelerates Invasiveness of Cancer Cells in Recurrent Epithelial Ovarian Cancer Through Regulation of Homeobox A9.
Chong GO; Jeon HS; Han HS; Son JW; Lee YH; Hong DG; Park HJ; Lee YS; Cho YL
Cancer Genomics Proteomics; 2017; 14(2):137-141. PubMed ID: 28387653
[TBL] [Abstract][Full Text] [Related]
10. Delta tocotrienol in recurrent ovarian cancer. A phase II trial.
Thomsen CB; Andersen RF; Steffensen KD; Adimi P; Jakobsen A
Pharmacol Res; 2019 Mar; 141():392-396. PubMed ID: 30639384
[TBL] [Abstract][Full Text] [Related]
11. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
Singh A; Gupta S; Badarukhiya JA; Sachan M
Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
[TBL] [Abstract][Full Text] [Related]
12. High level of homeobox A9 and PBX homeobox 3 expression in gastric cancer correlates with poor prognosis.
Ma YY; Zhang Y; Mou XZ; Liu ZC; Ru GQ; Li E
Oncol Lett; 2017 Nov; 14(5):5883-5889. PubMed ID: 29113222
[TBL] [Abstract][Full Text] [Related]
13. High
Li XF; Zhang HB; Huo Y
J Int Med Res; 2022 Nov; 50(11):3000605221135864. PubMed ID: 36366735
[TBL] [Abstract][Full Text] [Related]
14. Analysis of HOXA9 methylated ctDNA in ovarian cancer using sense-antisense measurement.
Faaborg L; Fredslund Andersen R; Waldstrøm M; Høgdall E; Høgdall C; Adimi P; Jakobsen A; Dahl Steffensen K
Clin Chim Acta; 2021 Nov; 522():152-157. PubMed ID: 34419462
[TBL] [Abstract][Full Text] [Related]
15.
Raunkilde L; Hansen TF; Andersen RF; Havelund BM; Thomsen CB; Jensen LH
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139621
[TBL] [Abstract][Full Text] [Related]
16. HOXA9 Expression is Associated with Advanced Tumour Stage and Prognosis in Nasopharyngeal Carcinoma.
Liu T; Ji C; Sun Y; Bai W
Cancer Manag Res; 2021; 13():4147-4154. PubMed ID: 34045901
[TBL] [Abstract][Full Text] [Related]
17. Validating Methylated HOXA9 in Bronchial Lavage as a Diagnostic Tool in Patients Suspected of Lung Cancer.
Wen SWC; Andersen RF; Rasmussen K; Thomsen CB; Hansen TF; Nederby L; Hager H; Jakobsen A; Hilberg O
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439376
[TBL] [Abstract][Full Text] [Related]
18. Frequent methylation of HOXA9 gene in tumor tissues and plasma samples from human hepatocellular carcinomas.
Kuo CC; Lin CY; Shih YL; Hsieh CB; Lin PY; Guan SB; Hsieh MS; Lai HC; Chen CJ; Lin YW
Clin Chem Lab Med; 2014 Aug; 52(8):1235-45. PubMed ID: 24681432
[TBL] [Abstract][Full Text] [Related]
19. Early identification of treatment benefit by methylated circulating tumor DNA in metastatic colorectal cancer.
Thomsen CB; Hansen TF; Andersen RF; Lindebjerg J; Jensen LH; Jakobsen A
Ther Adv Med Oncol; 2020; 12():1758835920918472. PubMed ID: 32518596
[TBL] [Abstract][Full Text] [Related]
20. CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patients.
Heinze K; Rengsberger M; Gajda M; Jansen L; Osmers L; Oliveira-Ferrer L; Schmalfeldt B; Dürst M; Häfner N; Runnebaum IB
Clin Epigenetics; 2021 Jan; 13(1):15. PubMed ID: 33482905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
